Abbott Laboratories (ABT)
ABT trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$102.61
+0.78% on the day
Market cap
$177.6B
Large cap
Revenue · 2025
$44.3B
+5.7% on 2024
Net income · 2025
$6.5B
14.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ABT on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000001800 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | IL |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $44.3B |
| Net income | $6.5B |
| Operating income | $8.1B |
| Net margin | 14.7% |
| Operating margin | 18.2% |
| Revenue growth | +5.7% |
| Cash | $8.5B |
| Total assets | $86.7B |
| P/E (computed) | 27.2× |
| P/S (computed) | 4.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-02-25 |
| Latest annual report | 10-K | 2026-02-20 |
| Latest quarterly / interim | 10-Q | 2026-07-28 |
| Latest current report FORM 8-K | 8-K | 2026-08-20 |
| Latest proxy DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | DEFA14A | 2026-03-13 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.3% |
| 1 month | +0.9% |
| 3 months | +4.2% |
| Year to date | -17.8% |
| 1 year | -21.6% |
| From 52-week high | -22.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NVO | Novo Nordisk A/S | $38.06 | -1.35% | $168.5B |
| PFE | Pfizer Inc. | $28.37 | -0.11% | $161.7B |
| AZN | AstraZeneca PLC | $155.82 | -1.58% | $241.6B |
| VRTX | Vertex Pharmaceuticals Incorporated | $485.22 | -4.30% | $123.0B |
| NVS | Novartis AG | $142.41 | -0.99% | $271.7B |
| BMY | Bristol-Myers Squibb Company | $56.67 | -1.58% | $115.8B |
| SNY | Sanofi ADS | $39.12 | -1.56% | $95.4B |
| GSK | GSK plc | $46.27 | -1.39% | $93.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier